AI-generated summary
This review reports that medical treatments, alone or combined with phototherapy, are key approaches for nonsegmental vitiligo and, to a lesser extent, segmental vitiligo. The authors state the treatments can halt progression, induce repigmentation and reduce relapse risk, though they have side effects and limitations. They also note that newer systemic and topical agents may offer more effective approaches in the future.
- Who or what was studied
- People with nonsegmental or segmental vitiligo
- Limits stated in the abstract
- The abstract gives no included study count, quantitative efficacy data or specific treatment details, and mentions side effects and limitations without describing them.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.